N-of-One® Teams with the Personalized Medicine Coalition (PMC) to Support Physician Education on the Complexities of Interpreting NGS Panels in Oncology

  • Posted by Emily Haynes
  • On November 18, 2015
  • 0 Comments
LEXINGTON, Mass., November 18, 2015 – N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, announced today that N-of-One has contributed its first article Empowering Physicians to Deliver Precision Medicine: The Role of Clinical Interpretation, to the PMC’s Education and Advocacy blog. The Personalized Medicine Coalition has invited N-of-One to join other PMC members […]
Read More

N-of-One Selected by WuXi NextCODE for Global Relationship, to Provide Clinical and Scientific Evidence for Interpretation for Cancer

  • Posted by Emily Haynes
  • On November 17, 2015
  • 0 Comments
LEXINGTON, Mass., November 17, 2015 – N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a global agreement with WuXi NextCODE to provide clinical and scientific evidence for delivering the best personalized treatment options based on the results of WuXi NextCODE tumor-normal genome sequence interpretation, which identifies key […]
Read More
BACK TO
TOP
LEARN
MORE